HHS Secretary Kennedy Approves Changes to CDC Vaccine Advisory Committee Rules

The updated charter includes directives to identify gaps in vaccine safety research, including adverse effects following vaccination.

It also requires consideration of the cumulative effects of all recommended childhood vaccines and ingredients such as aluminum, which is used in small amounts to enhance immune response. Some studies have examined potential links between aluminum and neurodevelopmental issues like autism, though large-scale research has found no connection.

Additionally, the committee is now tasked with evaluating novel vaccine platforms, including mRNA technology used in two COVID-19 vaccines available in the US, and reviewing vaccine schedules from other countries.

State and school requirements often align with these recommendations.

A spokesperson described the charter renewal as meeting routine statutory requirements and stated it does not indicate any broader policy shift.

“Unless officially announced by HHS, any assertions about next steps are speculation.”

A former CDC official commented on the changes. He noted the charter's emphasis on risks and the inclusion of non-voting liaison members from organizations skeptical of vaccines. These groups assert that vaccine risks are underreported and that benefits may not outweigh harms.

A lawyer representing medical associations in a lawsuit stated that the focus on adverse events could reorient ACIP's mandate. The lawsuit challenges changes to vaccine policy at the agency. Affected parties include healthcare providers, parents, insurers, and public health officials, with potential implications for vaccine access and public trust.

Next steps may involve ACIP resuming operations under the new charter, though HHS has not announced specific plans. The revisions could influence future vaccine recommendations and related policies.

The US Department of Health and Human Services announced changes to the rules governing the Advisory Committee on Immunization Practices, or ACIP, which advises the Centers for Disease Control and Prevention on vaccine recommendations. Officials approved the revisions, which broaden the committee's focus beyond previous limitations on US vaccine use recommendations.

The changes follow a March court order that temporarily blocked ACIP's operations and placed some prior decisions on hold. ACIP was established in 1964 to review vaccine data and provide recommendations that influence insurance coverage and government purchases for low-income children.